← Back to Search

Mindfulness Training

IBMT mindfulness for Cognitive Decline

N/A
Waitlist Available
Led By YiYuan Tang
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
Awards & highlights

Study Summary

This trial will help researchers understand how well body-mind training works to improve thinking skills and prevent decline.

Eligible Conditions
  • Cognitive Decline

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome measures are assessed in-person at baseline, 2-4 weeks and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention effects on cognitive decline
Intervention effects on emotion regulation
Intervention effects on mindfulness
+1 more
Secondary outcome measures
Intervention effects on brain function
Intervention effects on brain grey matter
Intervention effects on brain white matter

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IBMT mindfulnessExperimental Treatment1 Intervention
An evidence-based preventive intervention - integrative body-mind training (IBMT) has shown positive effects in reducing stress, and improving self-control and brain plasticity related to cognitive performance. It has bodifulness and mindfulness components.
Group II: health educationActive Control1 Intervention
Health education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IBMT mindfulness
2021
N/A
~40

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,474 Total Patients Enrolled
1 Trials studying Cognitive Decline
216 Patients Enrolled for Cognitive Decline
YiYuan TangPrincipal InvestigatorArizona State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being accepted for this research endeavor at present?

"That is accurate. According to the clinicaltrials.gov repository, this research project - posted on July 4th 2022 and last updated one day later - is actively recruiting 40 subjects at a single medical centre."

Answered by AI

What is the participant intake for this research?

"Affirmative, the clinicaltrials.gov website states that this medical trial is actively seeking participants as of July 5th 2022. The initial post was made on July 4th and 40 individuals from 1 site are needed for participation in the study."

Answered by AI

Are elderly members of the population being included in this medical research?

"This research is seeking out individuals over 40 years of age, but below 65 to participate."

Answered by AI

To what demographic is this trial specifically tailored?

"Aspiring participants must meet a number of qualifications in order to be enrolled into this research trial. Specifically, patients aged 40-65 with self-reported cognitive decline must possess the capacity to understand English, pass standardized cognitive tests, consent for non-invasive fMRI scans and not have any severe psychiatric diagnoses or medication that may interfere with their participation."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
How old are they?
18 - 65
What site did they apply to?
Arizona State University
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~9 spots leftby May 2025